Eleven clinical studies presented at RSNA 2024 highlighted the growing clinician experience with the Swoop® system for imaging diverse patient groups in emergency departments and neuro ICUs.

Hyperfine, Inc. (NASDAQ:HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® system—today highlighted data and conclusions presented at the Radiological Society of North America (RSNA) 2024 Annual Meeting in Chicago. Contributions from eleven leading institutions—early adopters of point-of-care MR brain imaging technology—underscore the increasing utility of AI-powered portable MR imaging and the growing physician experience with its application, particularly for acute stroke diagnosis.